Trademark: 90639165
Word
BELLA
Status Date
Monday, January 29, 2024
Filing Date
Monday, April 12, 2021
Published for Opposition
Tuesday, November 1, 2022
Abandoned Date
Monday, January 29, 2024
9 Downloadable computer application software for mobile phones, namely, software for covid-19 and other infectious disease identification; Downloadable computer application software for computers, namely, software for covid-19 and other infectious disease identification; Downloadable mobile applications for health screenings relating to COVID-19 and other infectious disease; Downloadable mobile applications for tracking and reporting health conditions and symptoms; Scientific apparatus and instruments, namely, COVID-19 rapid tests for withdrawing and testing respiratory droplets for clinical, medical, research, and scientific purposes and parts and fittings thereof; Material testing apparatus and instruments, for identifying and testing pathogens and biomarkers in respiratory droplets for clinical, medical, research, and scientific purposes related to COVID-19 and other infectious diseases; Apparatus for transmission of communication; Monitoring, measuring, signaling and control apparatus and instruments for testing respiratory droplets against a panel of biomarkers for clinical, medical, research, and scientific purposes, namely, for COVID-19 and other infectious diseases
5 Diagnostic kits comprised of medical diagnostic assays for use in disease detection, screening, treating and monitoring, namely, monitoring COVID-19 and other infectious diseases; Respiratory rapid tests, namely, medical diagnostic assays for use in performing respiratory rapid tests related to COVID-19 and other infectious diseases; Medical diagnostic kits comprised of reagents and assays for use in disease detection, screening, treating and monitoring, including, monitoring COVID-19 and other infectious diseases and also including swabs, including nasal and throat swabs, and medical sample tubes; COVID-19 rapid tests comprising medical diagnostic reagents and assays for withdrawing and testing respiratory droplets and also including parts and fittings thereof
44 Healthcare services, namely, treatment of patients for infectious diseases or medical disorders; Medical and healthcare information, consultancy and advisory services relating to infections, viruses, SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Providing a web site featuring medical information; Health care services, namely, disease management programs; Telehealth services, namely, providing telemedicine and services in conjunction with providing medical and healthcare services; Mobile healthcare services in the field of Covid-19 and other infectious disease testing, health assessments, intravenous infusion therapy, facilitating appointments; Medical screening services in the field of Covid-19 and other infectious diseases in a patient; Polymerase chain reaction (PCR) testing, rapid body antigen testing, and nucleic acid amplification testing for identifying and testing pathogens and biomarkers in respiratory droplets for medical diagnostic purposes related to COVID-19 and other infectious diseases
10 Medical instruments, namely, biosensors for detecting Covid-19 and other infectious diseases in a patient; Monitoring, measuring, signaling and control apparatus and instruments for testing respiratory droplets against a panel of biomarkers for medical diagnostic purposes, namely, for COVID-19 and other infectious disease
42 Providing temporary use of online non-downloadable software for use in the testing and diagnosis of COVID-19, coronavirus, and other diseases; Providing temporary use of online non-downloadable software for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Providing temporary use of web-based software applications for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Software as a service (SAAS) services featuring software for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Electronic storage of information concerning persons infected with contagious disease for the purpose slowing or stopping the spread of the disease under the guidance of state and local public health departments, and information concerning physical sites visited by persons infected with contagious disease for the purpose slowing or stopping the spread of the disease under the guidance of state and local public health departments
The mark consists of the word BELLA in a stylized font. The A in the mark resembles an inverted V.
Jan 29, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 29, 2024
Abandonment - No Use Statement Filed
Jul 6, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 5, 2023
Sou Extension 1 Granted
Jun 27, 2023
Sou Extension 1 Filed
Jul 3, 2023
Case Assigned To Intent To Use Paralegal
Jun 27, 2023
Sou Teas Extension Received
Apr 19, 2023
Teas Change Of Correspondence Received
Apr 19, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 19, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 27, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 1, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 1, 2022
Published For Opposition
Oct 12, 2022
Notification Of Notice Of Publication E-Mailed
Sep 29, 2022
Approved For Pub - Principal Register
Sep 21, 2022
Examiner's Amendment Entered
Sep 21, 2022
Notification Of Examiners Amendment E-Mailed
Sep 21, 2022
Examiners Amendment E-Mailed
Sep 21, 2022
Examiners Amendment -Written
Jun 1, 2022
Teas/Email Correspondence Entered
May 31, 2022
Correspondence Received In Law Office
May 31, 2022
Teas Response To Office Action Received
Apr 8, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 8, 2022
Teas Change Of Correspondence Received
Apr 8, 2022
Teas Change Of Owner Address Received
Dec 1, 2021
Notification Of Non-Final Action E-Mailed
Dec 1, 2021
Non-Final Action E-Mailed
Dec 1, 2021
Non-Final Action Written
Nov 30, 2021
Assigned To Examiner
Jul 19, 2021
New Application Office Supplied Data Entered
Apr 15, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
